Cargando…

Inhibitory Effects of Breast Milk-Derived Lactobacillus rhamnosus Probio-M9 on Colitis-Associated Carcinogenesis by Restoration of the Gut Microbiota in a Mouse Model

Chronic inflammation is a risk factor for colorectal cancer, and inflammatory cytokines secreted from inflammatory cells and active oxygen facilitate tumorigenesis. Intestinal bacteria are thought to regulate tumorigenesis. The longer the breastfeeding period, the lower is the risk of inflammatory b...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Haiyan, Hiraishi, Keizo, Kurahara, Lin-Hai, Nakano-Narusawa, Yuko, Li, Xiaodong, Hu, Yaopeng, Matsuda, Yoko, Zhang, Heping, Hirano, Katsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065529/
https://www.ncbi.nlm.nih.gov/pubmed/33808480
http://dx.doi.org/10.3390/nu13041143
_version_ 1783682362766262272
author Xu, Haiyan
Hiraishi, Keizo
Kurahara, Lin-Hai
Nakano-Narusawa, Yuko
Li, Xiaodong
Hu, Yaopeng
Matsuda, Yoko
Zhang, Heping
Hirano, Katsuya
author_facet Xu, Haiyan
Hiraishi, Keizo
Kurahara, Lin-Hai
Nakano-Narusawa, Yuko
Li, Xiaodong
Hu, Yaopeng
Matsuda, Yoko
Zhang, Heping
Hirano, Katsuya
author_sort Xu, Haiyan
collection PubMed
description Chronic inflammation is a risk factor for colorectal cancer, and inflammatory cytokines secreted from inflammatory cells and active oxygen facilitate tumorigenesis. Intestinal bacteria are thought to regulate tumorigenesis. The longer the breastfeeding period, the lower is the risk of inflammatory bowel disease. Here, we investigated preventive effects of the probiotic Lactobacillus rhamnosus M9 (Probio-M9) on colitis-associated tumorigenesis. An inflammatory colorectal tumor model was established using a 6-week-old male C57BL/6NCrSlc mouse, which was intraperitoneally administered with azoxymethane (AOM: 12 mg/kg body weight). On weeks 2 and 4, 2% dextran sulfate sodium (DSS) was administered to mice for 7 days through drinking water. On weeks 8 and 10, Probio-M9 (2 × 10(9)/day) was orally administered for 7 days. Animals were sacrificed at 20 weeks after AOM administration and immunohistochemical staining and Western blotting was performed. The α-diversity of microflora (Shannon index), principal coordinate analysis, and distribution of intestinal bacterium genera and metabolic pathways were compared. The AOM/DSS group showed weight loss, diarrhea, intestinal shortening, increased number of colon tumors, proliferating tumorigenesis, increased inflammation score, fibrosis, increased CD68+, or CD163+ macrophage cells in the subserosal layer of non-tumor areas. Inflammation and tumorigenesis ameliorated after Probio-M9 treatment. Fecal microbial functions were altered by AOM/DSS treatment. Probio-M9 significantly upregulated the fecal microbial diversity and reversed fecal microbial functions. Thus, Probio-M9 could suppress tumor formation in the large intestine by regulating the intestinal environment and ameliorating inflammation, suggesting its therapeutic potential for treatment of inflammation and colitis-associated tumorigenesis.
format Online
Article
Text
id pubmed-8065529
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80655292021-04-25 Inhibitory Effects of Breast Milk-Derived Lactobacillus rhamnosus Probio-M9 on Colitis-Associated Carcinogenesis by Restoration of the Gut Microbiota in a Mouse Model Xu, Haiyan Hiraishi, Keizo Kurahara, Lin-Hai Nakano-Narusawa, Yuko Li, Xiaodong Hu, Yaopeng Matsuda, Yoko Zhang, Heping Hirano, Katsuya Nutrients Article Chronic inflammation is a risk factor for colorectal cancer, and inflammatory cytokines secreted from inflammatory cells and active oxygen facilitate tumorigenesis. Intestinal bacteria are thought to regulate tumorigenesis. The longer the breastfeeding period, the lower is the risk of inflammatory bowel disease. Here, we investigated preventive effects of the probiotic Lactobacillus rhamnosus M9 (Probio-M9) on colitis-associated tumorigenesis. An inflammatory colorectal tumor model was established using a 6-week-old male C57BL/6NCrSlc mouse, which was intraperitoneally administered with azoxymethane (AOM: 12 mg/kg body weight). On weeks 2 and 4, 2% dextran sulfate sodium (DSS) was administered to mice for 7 days through drinking water. On weeks 8 and 10, Probio-M9 (2 × 10(9)/day) was orally administered for 7 days. Animals were sacrificed at 20 weeks after AOM administration and immunohistochemical staining and Western blotting was performed. The α-diversity of microflora (Shannon index), principal coordinate analysis, and distribution of intestinal bacterium genera and metabolic pathways were compared. The AOM/DSS group showed weight loss, diarrhea, intestinal shortening, increased number of colon tumors, proliferating tumorigenesis, increased inflammation score, fibrosis, increased CD68+, or CD163+ macrophage cells in the subserosal layer of non-tumor areas. Inflammation and tumorigenesis ameliorated after Probio-M9 treatment. Fecal microbial functions were altered by AOM/DSS treatment. Probio-M9 significantly upregulated the fecal microbial diversity and reversed fecal microbial functions. Thus, Probio-M9 could suppress tumor formation in the large intestine by regulating the intestinal environment and ameliorating inflammation, suggesting its therapeutic potential for treatment of inflammation and colitis-associated tumorigenesis. MDPI 2021-03-30 /pmc/articles/PMC8065529/ /pubmed/33808480 http://dx.doi.org/10.3390/nu13041143 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Xu, Haiyan
Hiraishi, Keizo
Kurahara, Lin-Hai
Nakano-Narusawa, Yuko
Li, Xiaodong
Hu, Yaopeng
Matsuda, Yoko
Zhang, Heping
Hirano, Katsuya
Inhibitory Effects of Breast Milk-Derived Lactobacillus rhamnosus Probio-M9 on Colitis-Associated Carcinogenesis by Restoration of the Gut Microbiota in a Mouse Model
title Inhibitory Effects of Breast Milk-Derived Lactobacillus rhamnosus Probio-M9 on Colitis-Associated Carcinogenesis by Restoration of the Gut Microbiota in a Mouse Model
title_full Inhibitory Effects of Breast Milk-Derived Lactobacillus rhamnosus Probio-M9 on Colitis-Associated Carcinogenesis by Restoration of the Gut Microbiota in a Mouse Model
title_fullStr Inhibitory Effects of Breast Milk-Derived Lactobacillus rhamnosus Probio-M9 on Colitis-Associated Carcinogenesis by Restoration of the Gut Microbiota in a Mouse Model
title_full_unstemmed Inhibitory Effects of Breast Milk-Derived Lactobacillus rhamnosus Probio-M9 on Colitis-Associated Carcinogenesis by Restoration of the Gut Microbiota in a Mouse Model
title_short Inhibitory Effects of Breast Milk-Derived Lactobacillus rhamnosus Probio-M9 on Colitis-Associated Carcinogenesis by Restoration of the Gut Microbiota in a Mouse Model
title_sort inhibitory effects of breast milk-derived lactobacillus rhamnosus probio-m9 on colitis-associated carcinogenesis by restoration of the gut microbiota in a mouse model
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065529/
https://www.ncbi.nlm.nih.gov/pubmed/33808480
http://dx.doi.org/10.3390/nu13041143
work_keys_str_mv AT xuhaiyan inhibitoryeffectsofbreastmilkderivedlactobacillusrhamnosusprobiom9oncolitisassociatedcarcinogenesisbyrestorationofthegutmicrobiotainamousemodel
AT hiraishikeizo inhibitoryeffectsofbreastmilkderivedlactobacillusrhamnosusprobiom9oncolitisassociatedcarcinogenesisbyrestorationofthegutmicrobiotainamousemodel
AT kuraharalinhai inhibitoryeffectsofbreastmilkderivedlactobacillusrhamnosusprobiom9oncolitisassociatedcarcinogenesisbyrestorationofthegutmicrobiotainamousemodel
AT nakanonarusawayuko inhibitoryeffectsofbreastmilkderivedlactobacillusrhamnosusprobiom9oncolitisassociatedcarcinogenesisbyrestorationofthegutmicrobiotainamousemodel
AT lixiaodong inhibitoryeffectsofbreastmilkderivedlactobacillusrhamnosusprobiom9oncolitisassociatedcarcinogenesisbyrestorationofthegutmicrobiotainamousemodel
AT huyaopeng inhibitoryeffectsofbreastmilkderivedlactobacillusrhamnosusprobiom9oncolitisassociatedcarcinogenesisbyrestorationofthegutmicrobiotainamousemodel
AT matsudayoko inhibitoryeffectsofbreastmilkderivedlactobacillusrhamnosusprobiom9oncolitisassociatedcarcinogenesisbyrestorationofthegutmicrobiotainamousemodel
AT zhangheping inhibitoryeffectsofbreastmilkderivedlactobacillusrhamnosusprobiom9oncolitisassociatedcarcinogenesisbyrestorationofthegutmicrobiotainamousemodel
AT hiranokatsuya inhibitoryeffectsofbreastmilkderivedlactobacillusrhamnosusprobiom9oncolitisassociatedcarcinogenesisbyrestorationofthegutmicrobiotainamousemodel